EAN News

Neuromuscular patients management in the COVID era Neuromuscular diseases are a group of heterogenic rare conditions, that can be due to a genetic cause, inflammatory processes or dysimmune disorders. Pathogenic processes can affect motor neurons, peripheral nerves, neuromuscular junction, or… Continue Reading

Due to the CoVID-19 pandemic spread, most outpatient facilities have been strictly regulated, thus making it difficult for many patients suffering from chronic pain to access treatment. During this tough period, all pain physicians, including neurologists, are working to find… Continue Reading

The Covid-19 global pandemic is having a dramatic impact on many chronic conditions including those affecting neurological patients and among them those with movement disorders. In many cases, to protect vulnerable movement disorders patients from becoming infected, appointments have been… Continue Reading

Specific challenges at present regarding Covid-19 and how these are being addressed
Highly pathogenic coronavirus infections are well-established sources of previous epidemics (severe acute respiratory syndrome coronavirus: SARS‐CoV, Middle East respiratory syndrome coronavirus: MERS‐CoV). Of interest, the novel coronavirus named… Continue Reading

Online registration for the EAN Virtual Congress 2020 (May 23-26) is now OPEN!

We are excited to announce that we have improved our online community platform, MyEAN!

Latvia is a scenic country, situated on the shore of Baltic sea in Northern Europe, located between two other Baltic states: Estonia and Lithuania. The name Latvia comes from the ancient tribe called Latgalians who are one of four Indo-European Baltic ancestral tribes which inhabited the region within modern day Lativa. The country has a coastline of more than 500 km along the Baltic Sea, giving everybody the possibility to explore many white sand beaches all year round. More than 50% of the country is filled with precious “green gold” – forests – combined with gorgeous landscapes, rivers and lakes.

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus causes a pneumonia syndrome, with specific and already well-described symptoms, and fatal outcome in a subset of patients. The lungs are… Continue Reading

Tim J von Oertzen, Ronan McGinty, Martin Holtkamp, Reetta Kalviainen, Stephan Ruegg, Eugen Trinka, Guido Rubboli 3rd April 2020 Physicians of all specialties worldwide are challenged by the new SARS-CoV-2 virus causing corona virus disease 2019 (COVID-19). The virus is… Continue Reading

During the Covid-19 pandemic, most European countries have imposed personal restrictions on their populations in order to inhibit viral transmission and spread of infection. The hardest restriction concerns the imposition not to leave home unless to go to the supermarket,… Continue Reading

by Ettore Beghi & Daniel Berekzcki An unexpected outbreak due to the infection by the coronavirus, Covid-19, which started in China at the end of 2019, is rapidly expanding and is now officially assigned pandemic status by the WHO. After… Continue Reading

Covid-19 has affected over 500,000 people and caused over 21,000 deaths. People from all over the world are making great sacrifices, from social distancing to sustaining economic loss. Healthcare workers are on the frontline, and neurologists are increasingly involved as well.

In these troubled times, our Paper of the Month for April is: Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the Covid-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response.

As the number of COVID-19 cases continues to rise in the majority of European Countries, including Italy, neurologists should prepare to manage these cases. As already known, preparation has been challenged by rapidly changing guidelines, inconsistent directives, and a lack of testing capability.